Gordon Pledger

5.0k total citations
54 papers, 3.7k citations indexed

About

Gordon Pledger is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Statistics and Probability. According to data from OpenAlex, Gordon Pledger has authored 54 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 24 papers in Pediatrics, Perinatology and Child Health and 15 papers in Statistics and Probability. Recurrent topics in Gordon Pledger's work include Epilepsy research and treatment (27 papers), Pharmacological Effects and Toxicity Studies (24 papers) and Neuroscience and Neuropharmacology Research (12 papers). Gordon Pledger is often cited by papers focused on Epilepsy research and treatment (27 papers), Pharmacological Effects and Toxicity Studies (24 papers) and Neuroscience and Neuropharmacology Research (12 papers). Gordon Pledger collaborates with scholars based in United States, United Kingdom and Denmark. Gordon Pledger's co-authors include R. Reife, Rezaul Karim, Pilar Lim, Rǎjesh C. Sachdeo, L. D. Kramer, F. J. Ritter, Tracy A. Glauser, D. L. Hanson, Qing Liu and Lynn D. Kramer and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Statistical Association and Neurology.

In The Last Decade

Gordon Pledger

53 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon Pledger United States 26 2.4k 2.1k 1.0k 420 383 54 3.7k
Jaap W. Mandema United States 30 287 0.1× 269 0.1× 441 0.4× 300 0.7× 91 0.2× 59 3.5k
Brian Corrigan United States 23 410 0.2× 225 0.1× 121 0.1× 299 0.7× 56 0.1× 69 2.1k
Norbert Benda Germany 21 234 0.1× 208 0.1× 62 0.1× 211 0.5× 146 0.4× 83 1.9k
Andrea Jorgensen United Kingdom 32 229 0.1× 488 0.2× 44 0.0× 355 0.8× 109 0.3× 107 3.7k
Bart A. Ploeger Netherlands 26 115 0.0× 274 0.1× 143 0.1× 145 0.3× 211 0.6× 67 2.3k
Werner Brannath Austria 35 303 0.1× 142 0.1× 62 0.1× 1.7k 4.1× 142 0.4× 119 3.7k
Alexander Tsodikov United States 30 176 0.1× 120 0.1× 60 0.1× 395 0.9× 261 0.7× 75 3.0k
Jing Qian United States 29 472 0.2× 81 0.0× 825 0.8× 85 0.2× 496 1.3× 92 3.2k
Mahesh N. Samtani United States 24 594 0.2× 204 0.1× 42 0.0× 90 0.2× 107 0.3× 57 1.4k
Erica Bowton United States 20 137 0.1× 246 0.1× 593 0.6× 118 0.3× 30 0.1× 30 2.0k

Countries citing papers authored by Gordon Pledger

Since Specialization
Citations

This map shows the geographic impact of Gordon Pledger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Pledger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Pledger more than expected).

Fields of papers citing papers by Gordon Pledger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Pledger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Pledger. The network helps show where Gordon Pledger may publish in the future.

Co-authorship network of co-authors of Gordon Pledger

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Pledger. A scholar is included among the top collaborators of Gordon Pledger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Pledger. Gordon Pledger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wise, Robert A., Antonio Anzueto, Otto W. Witte, et al.. (2013). Tiotropium Respimat Inhaler and the Risk of Death in COPD. New England Journal of Medicine. 369(16). 1491–1501. 256 indexed citations
2.
Wise, Robert A., Antonio Anzueto, Peter M.A. Calverley, et al.. (2013). The Tiotropium Safety and Performance in Respimat® Trial (TIOSPIR®), a large scale, randomized, controlled, parallel-group trial-design and rationale. Respiratory Research. 14(1). 40–40. 42 indexed citations
3.
Stringer, Mark D. & Gordon Pledger. (2003). Childhood appendicitis in the United Kingdom: fifty years of progress. Journal of Pediatric Surgery. 38(7). 65–69. 14 indexed citations
4.
Wapenaar, Robert, et al.. (2003). A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Acta Neurologica Scandinavica. 108(1). 9–15. 24 indexed citations
5.
Pledger, Gordon & Mark D. Stringer. (2001). Childhood deaths from acute appendicitis in England and Wales 1963-97: observational population based study. BMJ. 323(7310). 430.1–431. 14 indexed citations
6.
Pledger, Gordon. (2001). Proof of efficacy trials: choosing the dose. Epilepsy Research. 45(1-3). 23–28. 4 indexed citations
7.
Deeks, Jonathan J, et al.. (2000). Number needed to treat: properties and problems - Comments. Oxford University Research Archive (ORA) (University of Oxford). 163. 415–417. 4 indexed citations
8.
Reife, R., et al.. (2000). Topiramate as Add‐On Therapy: Pooled Analysis of Randomized Controlled Trials in Adults. Epilepsia. 41(s1). 66–71. 133 indexed citations
9.
Lesaffre, Emmanuel, Paul Boon, & Gordon Pledger. (2000). The Value of the Number‐Needed‐to‐Treat Method in Antiepileptic Drug Trials. Epilepsia. 41(4). 440–446. 12 indexed citations
11.
Sachdeo, Rǎjesh C., R. Reife, Pilar Lim, & Gordon Pledger. (1997). Topiramate Monotherapy for Partial Onset Seizures. Epilepsia. 38(3). 294–300. 131 indexed citations
12.
Sharief, M. K., C. Viteri, Elinor Ben‐Menachem, et al.. (1996). Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Research. 25(3). 217–224. 144 indexed citations
13.
Privitera, Michael, Richard W. Fincham, J. K. Penry, et al.. (1996). Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Neurology. 46(6). 1678–1683. 286 indexed citations
14.
Faught, Edward, R. Eugene Ramsay, R. Reife, et al.. (1996). Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology. 46(6). 1684–1690. 244 indexed citations
15.
Tassinari, C. A., Roberto Michelucci, Patrick Chauvel, et al.. (1996). Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy. Epilepsia. 37(8). 763–768. 159 indexed citations
16.
Ben‐Menachem, Elinor, Olaf Henriksen, Mogens Dam, et al.. (1996). Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures. Epilepsia. 37(6). 539–543. 206 indexed citations
17.
Pledger, Gordon & Dieter Schmidt. (1994). Evaluation of Antiepileptic Drug Efficacy. Drugs. 48(4). 498–509. 18 indexed citations
18.
Pledger, Gordon, et al.. (1992). Pharmacokinetic and Dose Tolerability Study of ADD 94057 in Comedicated Patients with Partial Seizures. Epilepsia. 33(1). 112–118. 3 indexed citations
19.
Pledger, Gordon & David M. Treiman. (1991). Design of an individualized fixed-dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentration. Controlled Clinical Trials. 12(6). 768–779. 9 indexed citations
20.
Pledger, Gordon & Frank Proschan. (1973). Stochastic comparisons of random processes, with applications in reliability. Journal of Applied Probability. 10(3). 572–585. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026